Benzinga
Benzinga
Benzinga
jeudi, septembre 17

BrightSpring Health Services Inc

BTSGNASDAQ
Trade with Public
Trade with Public
$58.96
0.120.2%
À la clôture: Sep 16, 5:00 PM EST
$58.96
N/A
Après les heures: 7:49 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

BrightSpring Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for BrightSpring Health (BTSG).

Price Target Range — 11 Quarters

Analyst Consensus — 19 Analysts

1S.Buy
17Buy
1Hold
Consensus RatingBuy# Analysts19Avg. Consensus PT$54Upside to Avg. PT-8.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Aug 13, 2026BTIGDavid LarsenMaintainedBuy$90
Aug 3, 2026BTIGDavid LarsenMaintainedBuy$90
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $80

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $71 to $80.
Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on BrightSpring Health, Raises Price Target to $80

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $60 to $80.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $78

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $61 to $78.
Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $81

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $81.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved